Literature DB >> 17909704

Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.

A Iorio1, M C Vedovati, E Filippucci, G Agnelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17909704     DOI： 10.1007/s11739-007-0058-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   5.472


× No keyword cloud information.
  23 in total

1.  Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.

Authors:  Theodore E Warkentin; Richard A Bernstein
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245

2.  Heparin-induced thrombocytopenia associated with fondaparinux.

Authors:  Theodore E Warkentin; Brian T Maurer; Richard H Aster
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

3.  Thrombocytopenia during heparin therapy.

Authors: 
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

4.  Neurologic complications in immune-mediated heparin-induced thrombocytopenia.

Authors:  C Pohl; U Harbrecht; A Greinacher; I Theuerkauf; R Biniek; P Hanfland; T Klockgether
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

Review 5.  Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.

Authors:  Leigh E Efird; Denise R Kockler
Journal:  Ann Pharmacother       Date:  2006-06-20       Impact factor: 3.154

6.  Cerebral venous thrombosis due to heparin-induced thrombocytopenia.

Authors:  A P Kyritsis; E C Williams; H S Schutta
Journal:  Stroke       Date:  1990-10       Impact factor: 7.914

7.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Authors:  S F de Bruijn; J Stam
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

Review 8.  Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Gregory W Albers; Pierre Amarenco; J Donald Easton; Ralph L Sacco; Philip Teal
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

10.  Reexposure to heparin of patients with heparin-associated antibodies.

Authors:  J Laster; R Elfrink; D Silver
Journal:  J Vasc Surg       Date:  1989-05       Impact factor: 4.268
View more
  2 in total

1.  Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.

Authors:  Adriano Alatri; Marina Foramitti; Oriana Paoletti; Anke Zimmermann; Sophie Testa
Journal:  Intern Emerg Med       Date:  2010-02-23       Impact factor: 3.397

2.  Thrombocytopenia during fondaparinux prophylaxis: HIT or something different?

Authors:  Giuseppe Re; Cristina Legnani
Journal:  Intern Emerg Med       Date:  2010-05-05       Impact factor: 3.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.